Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

pchop123 (76.57) Submitted: 5/22/2013 2:56:32 PM : Start Price: $5.48 SNSS Score: -2.05

lookout below

sirhc1978 (78.84) Submitted: 2/2/2013 5:24:44 PM : Start Price: $6.00 SNSS Score: -17.30

IMSIDE PICK

SnarkyApple (61.44) Submitted: 9/27/2012 4:32:36 PM : Start Price: $5.67 SNSS Score: +16.67

Shenanigans.

Turtlebale (54.63) Submitted: 9/11/2012 8:23:57 AM : Start Price: $3.83 SNSS Score: +30.05

attractive program

theMANzalone (69.46) Submitted: 3/14/2012 4:05:12 PM : Start Price: $2.45 SNSS Score: +108.96

2013 will kick into gear

velo15 (< 20) Submitted: 10/1/2011 4:53:30 PM : Start Price: $1.22 SNSS Score: +308.78

falling or at least a bobbing knife. . . should be a no brainer for the patient (both kinds...)

DanishDynamite (< 20) Submitted: 7/22/2011 4:38:21 AM : Start Price: $2.04 SNSS Score: +149.66

Finally, found its price range, before we reach a yes or no, it will spike on phase III news.

stemcells2011 (32.66) Submitted: 3/1/2011 10:56:34 AM : Start Price: $2.07 SNSS Score: +144.12

Very bullish long term.

archingstocks (< 20) Submitted: 1/10/2011 5:23:50 PM : Start Price: $2.97 SNSS Score: +57.39

Well funded, well staffed, good drug

akshara3000 (< 20) Submitted: 1/5/2011 6:10:19 PM : Start Price: $3.00 SNSS Score: +56.40

If phase 3 trial info is released midterm through the study, and it is as positive and consistent as previous results, the stock will jump remarkably, especially after being beaten down so badly since mid 2010. This thing could easily double or triple in a years time, since there is no reason not to believe that phase 3 results will be outstanding. That does not guarantee approval, but there should be money to be made well before that stage of the process. 25k shares at 66 cents and I will hold long term

1997amer (< 20) Submitted: 1/1/2011 5:05:18 PM : Start Price: $3.12 SNSS Score: +47.74

It is an oncology orphan drug!!! very likely wii be approved even with 4 -5 weeks improved survival.

motleyjmw (< 20) Submitted: 1/19/2007 1:48:31 PM : Start Price: $30.00 SNSS Score: -104.33

Biogen Idec is a beneficial owner